K
Kyungdong Pharm
KOSDAQ:011040
Kyungdong Pharm
KOSDAQ:011040
Price:
5 360
KRW
0.37%
Market Closed
Market Cap:
₩164.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Kyungdong Pharm
KOSDAQ:011040
|
KR |
|
P
|
Premier Polyfilm Ltd
NSE:PREMIERPOL
|
IN |
|
Kewell Technology Co Ltd
SSE:688551
|
CN |
|
H
|
Home Center Holdings Co Ltd
KOSDAQ:060560
|
KR |
|
Heliogen Inc
OTC:HLGN
|
US |
|
L
|
Largo Inc
NASDAQ:LGO
|
CA |
|
Bank Linth LLB AG
SIX:LINN
|
CH |
|
Exelixis Inc
NASDAQ:EXEL
|
US |
Multiples-Based Value
The Multiples-Based Value of one Kyungdong Pharm stock under the Base Case scenario is hidden KRW. Compared to the current market price of 5 360 KRW, Kyungdong Pharm is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Kyungdong Pharm Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Kyungdong Pharm Competitors
Kyungdong Pharm Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
K
|
Kyungdong Pharm
KOSDAQ:011040
|
164.9B KRW | 0.7 | 17.5 | 15 | 23.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
900.7B USD | 14 | 44.1 | 29.7 | 31.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.9B GBP | 5.3 | 30.7 | 16.9 | 23.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.8B USD | 4.7 | 16.7 | 10.4 | 12.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.5B CHF | 5.2 | 20.9 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
